IMproving PAtient undeRstanding of GEP TEst Results: Phase 4
Chief Investigator: Professor Dame Lesley Fallowfield
Joint Investigator: Professor Valerie Jenkins
Researchers: Ms Rachel Starkings, Lucy Matthews
Data Manager: Shirley May
IMPARTER 4 examines whether a short (8 min) film about Gene Expression Profiling (GEP) tests used in breast cancer (oncotype DX® or prosigna®) helps improve patients’ knowledge needed to inform decision making and enhance satisfaction with patient – clinician discussions. We hope that 250 patients will participate across centres in the UK.
To hear Professor Dame Lesley Fallowfield explain the study click here
Click here to read more Information about the study.